Henry Schein (NASDAQ:HSIC – Get Free Report) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 4.700-4.820 for the period, compared to the consensus estimate of 5.060. The company issued revenue guidance of $12.8 billion-$13.1 billion, compared to the consensus revenue estimate of $13.3 billion. Henry Schein also updated its FY24 guidance to $4.70-$4.82 EPS.
Wall Street Analyst Weigh In
A number of brokerages have commented on HSIC. Evercore ISI reduced their target price on shares of Henry Schein from $72.00 to $70.00 and set an in-line rating on the stock in a research note on Wednesday. Robert W. Baird reduced their target price on shares of Henry Schein from $92.00 to $82.00 and set an outperform rating on the stock in a research note on Wednesday. Baird R W raised shares of Henry Schein from a hold rating to a strong-buy rating in a research note on Monday, July 22nd. Piper Sandler reaffirmed an overweight rating and set a $86.00 target price on shares of Henry Schein in a research note on Friday, June 21st. Finally, UBS Group reduced their price target on shares of Henry Schein from $75.00 to $72.00 and set a neutral rating on the stock in a research note on Wednesday. One analyst has rated the stock with a sell rating, six have issued a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of Hold and an average price target of $77.90.
View Our Latest Analysis on Henry Schein
Henry Schein Stock Up 1.1 %
Henry Schein (NASDAQ:HSIC – Get Free Report) last announced its earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.01. Henry Schein had a net margin of 3.12% and a return on equity of 13.51%. The firm had revenue of $3.10 billion for the quarter, compared to the consensus estimate of $3.27 billion. During the same period in the prior year, the firm earned $1.31 EPS. The firm’s revenue for the quarter was up .0% on a year-over-year basis. Analysts predict that Henry Schein will post 5.16 EPS for the current fiscal year.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading
- Five stocks we like better than Henry Schein
- What is Forex and How Does it Work?
- The Cannabis Sector: Profitability Takes Center Stage
- 3 Stocks to Consider Buying in October
- Amazon’s Stock Plunge: Is a Prime Buying Opportunity Knocking?
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Buy the Dip in e.l.f. Beauty: Analysts Point to a New High
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.